Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc. (SUPN)
Filing Type: Form 8-K (Current Report)
Date of Report: February 11, 2020
Context: This filing announces the upcoming release of financial results for the fourth quarter and full year ended December 31, 2019.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notification of the timing for the release of these metrics.
Material Changes
No material changes to financial performance are detailed in this filing. The document contains no comparative data against prior periods.
Guidance, Outlook, and Management Commentary
- Results Release: Supernus expects to report Q4 and full-year 2019 results after 5:00 PM ET on Tuesday, February 25, 2020.
- Conference Call: A conference call and webcast to discuss the results are scheduled for Wednesday, February 26, 2020.
- Reference: A press release dated February 11, 2020, is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the actual financial results released on or after February 25, 2020.
- Review the conference call transcript scheduled for February 26, 2020, for management commentary on 2019 performance.
- Examine Exhibit 99.1 (Press Release) for any additional details not captured in the 8-K summary.